1. Wang, Shiyan, Gao, Shanshan, Zeng, Yong, Yu, Jun, He, Housheng Hansen. 2021. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer. In Gastroenterology, 162, 1183-1196. doi:10.1053/j.gastro.2021.12.269. https://pubmed.ncbi.nlm.nih.gov/34968454/
2. Ravindran, Ethiraj, Hu, Hao, Yuzwa, Scott A, Hübner, Christoph, Kaindl, Angela M. 2017. Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation. In PLoS genetics, 13, e1006746. doi:10.1371/journal.pgen.1006746. https://pubmed.ncbi.nlm.nih.gov/28453519/
3. Zhou, Pei, Qi, Yifei, Fang, Xiang, Kaindl, Angela M, Hu, Hao. 2021. Arhgef2 regulates neural differentiation in the cerebral cortex through mRNA m6A-methylation of Npdc1 and Cend1. In iScience, 24, 102645. doi:10.1016/j.isci.2021.102645. https://pubmed.ncbi.nlm.nih.gov/34142067/
4. Nakao, Yosuke, Nakagawa, Shigeki, Yamashita, Yo-Ichi, Imai, Katsunori, Baba, Hideo. 2021. High ARHGEF2 (GEF-H1) Expression is Associated with Poor Prognosis Via Cell Cycle Regulation in Patients with Pancreatic Cancer. In Annals of surgical oncology, 28, 4733-4743. doi:10.1245/s10434-020-09383-9. https://pubmed.ncbi.nlm.nih.gov/33393038/